Alligator Bioscience Ownership
| ATORX Stock | SEK 0.01 0.0003 3.80% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Alligator |
Alligator Stock Ownership Analysis
About 52.0% of the company shares are held by company insiders. The book value of Alligator Bioscience was presently reported as 0.4. The company recorded a loss per share of 0.6. Alligator Bioscience had not issued any dividends in recent years. The entity had 155:142 split on the 9th of November 2021. Alligator Bioscience AB develops antibody-based pharmaceuticals for cancer treatment. Alligator Bioscience AB was founded in 2001 and is headquartered in Lund, Sweden. Alligator Bioscience operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 56 people. For more info on Alligator Bioscience AB please contact the company at 46 4 65 40 82 00 or go to https://www.alligatorbioscience.se.Alligator Bioscience Outstanding Bonds
Alligator Bioscience issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Alligator Bioscience uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Alligator bonds can be classified according to their maturity, which is the date when Alligator Bioscience AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Alligator Stock Analysis
When running Alligator Bioscience's price analysis, check to measure Alligator Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alligator Bioscience is operating at the current time. Most of Alligator Bioscience's value examination focuses on studying past and present price action to predict the probability of Alligator Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alligator Bioscience's price. Additionally, you may evaluate how the addition of Alligator Bioscience to your portfolios can decrease your overall portfolio volatility.